United Kingdom · Life Sciences Lvl3
Respiro Diagnostics Ltd
Respiro Diagnostics Ltd is a UK early-stage company with 2 public funding or programme announcements on record, most recently 1 Jul 2026.
Announcements
Innovate UK funding awarded
£73,500 · Collaborative R&D grant; “Breath-based lung cancer diagnostics: clinical validation and commercial readiness”; Yorkshire and The Humber
Innovate UK funding awarded
£219,668 · Investment Accelerator grant; “Breath-based liquid biopsy for lung cancer: Device optimisation for NHS trials”; Yorkshire and The Humber
Is this your company?
Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.
Not a recommendation
Support or selection by Innovate UK is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.